Compounding Challenges for Immunocompromised Patients

Author(s):  McElhiney Linda F

Issue:  Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue

Abstract:  Compounding pharmacists play a vital role in the prevention, duration, and conclusion of diseases and infections for immunocompromised patients. Caused by deficiencies such as the human immunodeficiency virus, acquired immunodeficiency virus and cancers, which warrant immunosuppression during chemotherapy, immunodeficiency renders the patient vulnerable to viruses, infections, and diseases that, in the immunocompromised state, could develop lethally. By working closely with patients, compounding pharmacists are able to provide correct dosages, strengths, and drug combinations for each individual situation.

Related Keywords: Linda F. McElhiney, PharmD, RPh, immune deficiency, HIV, immunocompromised, immunosuppression, human immunodeficiency virus, AIDS, cancer chemotherapy, organ transplantation, bone marrow transplant, stem cell transplant, opportunistic infections, antifungal agents, antibiotics, antimicrobial agents, formulations

Related Categories: CANCER AND AIDS, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2851

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products